Assessment of 6-sulfatoxymelatonin rhythms and melatonin response to light in disease states: Lessons from cirrhosis

References

• Aldhous ME, Arendt J. (1988). Radioimmunoassay for 6-sulphatoxymelatonin in urine using an iodinated tracer. Ann Clin Biochem. 25:298–303
   PubMed Web of Science ®Google Scholar
• Bland JM, Altman DG. (1986). Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1:307–10
   PubMed Web of Science ®Google Scholar
• Bojkowski CJ, Arendt J, Shih MC, Markey SP. (1987). Melatonin secretion in humans assessed by measuring its metabolite, 6-sulfatoxymelatonin. Clin Chem. 33:1343–8
   PubMed Web of Science ®Google Scholar
• Breslow ER, Phillips AJ, Huang JM, et al. (2013). A mathematical model of the circadian phase-shifting effects of exogenous melatonin. J Biol Rhythms. 28:79–89
   PubMed Web of Science ®Google Scholar
• Brown EN, Choe Y, Shanahan TL, Czeisler CA. (1997). A mathematical model of diurnal variations and comparison to plasma melatonin levels. Am J Physiol Soc. 272:E506–16
   PubMed Web of Science ®Google Scholar
• Czeisler CA, Duffy JF, Shanahan TL, et al. (1999). Stability, precision, and near-24-hour period of the human circadian pacemaker. Science. 284:2177–81
   PubMed Web of Science ®Google Scholar
• Duffy JF, Dijk DJ. (2002). Getting through to circadian oscillators: Why use constant routines?. J Biol Rhythms. 17:4–13
   PubMed Web of Science ®Google Scholar
• Fraser S, Cowen P, Franklin M, et al. (1983). Direct radioimmunoassay for melatonin in plasma. Clin Chem. 29:396–7
   PubMed Web of Science ®Google Scholar
• Gamble KL, Berry R, Frank SJ, Young ME. (2014). Circadian clock control of endocrine factors. Nat Rev Endocrinol. 10:466–75
   PubMed Web of Science ®Google Scholar
• Jakobsen J, Pedersen AN, Ovesen L. (2003). Para-aminobenzoic acid (PABA) used as a marker for completeness of 24 hour urine: Effects of age and dosage scheduling. Eur J Clin Nutr. 57:138–42
   PubMed Web of Science ®Google Scholar
• Kircheis G, Wettstein M, Timmermann L, et al. (2002). Critical flicker frequency for quantification of low-grade hepatic encephalopathy. Hepatology. 35:357–66
   PubMed Web of Science ®Google Scholar
• Lockley SW, Skene DJ, James K, et al. (2000). Melatonin administration can entrain the free-running circadian system of blind subjects. J Endocrinol. 164:R1–6
   PubMed Web of Science ®Google Scholar
• MacDonald SWS, Nyberg L, Bäckman L. (2006). Intra-individual variability in behavior: Links to brain structure, neurotransmission and neuronal activity. Trends Neurosci. 29:474–80
   PubMed Web of Science ®Google Scholar
• Magri F, Sarra S, Cinchetti W, et al. (2004). Qualitative and quantitative changes of melatonin levels in physiological and pathological aging and in centenarians. J Pineal Res. 36:256–61
   PubMed Web of Science ®Google Scholar
• Mäntele S, Otway DT, Middleton B, et al. (2012). Daily rhythms of plasma melatonin, but not plasma leptin or leptin mRNA, vary between lean, obese and type 2 diabetic men. Plos One. 7:e37123
   PubMed Web of Science ®Google Scholar
• Maury E, Hong HK, Bass J. (2014). Circadian disruption in the pathogenesis of metabolic syndrome. Diabetes Metab. doi: 10.1016/j.diabet.2013.12.005. [Epub ahead of print]
   Google Scholar
• Middleton B. (2006). Measurement of melatonin and 6-sulphatoxymelatonin. Methods Mol Biol. 324:235–54
   PubMedGoogle Scholar
• Minors DS, Waterhouse JM. (1988). Mathematical and statistical analysis of circadian rhythms. Psychoneuroendocrinology. 13:443–64
   PubMed Web of Science ®Google Scholar
• Montagnese S, De Pittà C, De Rui M, et al. (2014). Sleep-wake abnormalities in patients with cirrhosis. Hepatology. 59:705–12
   PubMed Web of Science ®Google Scholar
• Montagnese S, Middleton B, Skene DJ, Morgan MY. (2009). Sleep-wake patterns in patients with cirrhosis: All you need to know on a single sheet. A simple sleep questionnaire for clinical use. J Hepatol. 51:690–5
   PubMed Web of Science ®Google Scholar
• Montagnese S, Middleton B, Mani AR, et al. (2010). On the origin and the consequences of circadian abnormalities in patients with cirrhosis. Am J Gastroenterol. 105:1773–81
   PubMed Web of Science ®Google Scholar
• Pääkkönen T, Mäkinen TM, Leppäluoto J, et al. (2006). Urinary melatonin: A noninvasive method to follow human pineal function as studied in three experimental conditions. J Pineal Res. 40:110–5
   PubMed Web of Science ®Google Scholar
• Portaluppi F, Smolensky MH, Touitou Y. (2010). Ethics and methods for biological rhythm research on animals and human beings. Chronobiol Int. 27:1911–29
   PubMed Web of Science ®Google Scholar
• Pérez-Rico C, de la Villa P, Arribas-Gómez I, Blanco R. (2010). Evaluation of functional integrity of the retinohypothalamic tract in advanced glaucoma using multifocal electroretinography and light-induced melatonin suppression. Exp Eye Res. 91:578–83
   PubMed Web of Science ®Google Scholar
• Reichenbach A, Faude F, Enzmann V, et al. (1997). The Müller (glial) cell in normal and diseased retina: A case for single-cell electrophysiology. Ophthalmic Res. 29:326–40
   PubMed Web of Science ®Google Scholar
• St Hilaire MA, Gronfier C, Zeitzer JM, Klerman EB. (2007a). A physiologically based mathematical model of melatonin including ocular light suppression and interactions with the circadian pacemaker. J Pineal Res. 43:294–304
   PubMed Web of Science ®Google Scholar
• St Hilaire MA, Klerman EB, Khalsa SBS, et al. (2007b). Addition of a non-photic component to a light-based mathematical model of the human circadian pacemaker. J Biol Rhythms. 247:583–99
   Google Scholar
• Steindl PE, Ferenci P, Marktl W. (1997). Impaired hepatic catabolism of melatonin in cirrhosis. Ann Intern Med. 127:494
   PubMed Web of Science ®Google Scholar
• Thapan K, Arendt J, Skene DJ. (2001). An action spectrum for melatonin suppression: Evidence for a novel non-rod, non-cone photoreceptor system in humans. J Physiol. 535:261–7
   PubMed Web of Science ®Google Scholar
• Yamazaki S, Numano R, Abe M, et al. (2000). Resetting central and peripheral circadian oscillators in transgenic rats. Science. 288:682–5
   PubMed Web of Science ®Google Scholar
• Youngstedt SD, Kripke DF, Elliott JA, Rex KM. (2005). Circadian phase-shifting effects of a laboratory environment: A clinical trial with bright and dim light. J Circadian Rhythms. 9:3–11
   Google Scholar